Sage Private Wealth Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50
Closed -$2K 57
2022
Q3
$2K Buy
+50
New +$1.84K ﹤0.01% 179

Other funds holding ARKG

Sage Private Wealth Group's ARKG Position: Q4 2022 in Review

Sage Private Wealth Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2022, closing a stake of 50 shares — an estimated $2K sold.

Sage Private Wealth Group first reported a position in ARKG in Q3 2022 and held it in 1 quarter. The position peaked at $2K in Q3 2022. 319 funds tracked by Wall St. Rank hold ARKG as of Q4 2022.

  • Sage Private Wealth Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2022 after selling out during the quarter.
  • Sage Private Wealth Group sold 50 ARK Genomic Revolution ETF shares in Q4 2022, an estimated $2K.
  • Sage Private Wealth Group first reported a position in ARK Genomic Revolution ETF in Q3 2022 and held it in 1 quarter.
  • Sage Private Wealth Group's ARK Genomic Revolution ETF position peaked at $2K in Q3 2022.
  • 319 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2022.

Based on Sage Private Wealth Group's 13F filing for Q4 2022, filed 29 Jan 2025.